Cardiac Diagnostics

This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.

Videos | Coronavirus (COVID-19) | March 17, 2020
Interview with Thomas Maddox, M.D., MSc, FACC, the chairman of the American College of Cardiology (ACC) Science and...
OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
ACC issues document outlining COVID-19 Implications For Patients With Underlying Cardiovascular Conditions. The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate. #COVID19 #coronavirus #2019nCoV #SARS‐CoV‐2

The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate.

Feature | Coronavirus (COVID-19) | March 09, 2020
March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel...
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the...
Coronavirus (COVID-19) and the FDA clearance of the Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony, topped the news analytics in February 2020 on DAIC magazine. COVID-19 virus image courtesy of CDC.

Coronavirus (COVID-19) and the FDA clearance of the Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony, topped the news analytics in February 2020 on DAIC magazine. COVID-19 virus image courtesy of CDC.

Feature | March 02, 2020 | Dave Fornell, Editor
March 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
An illustration of the novel coronavirus (COVID-19) from the CDC. #coronavirus #COVID19 #COVID-2019 #2019nCoV

An illustration of the novel coronavirus (COVID-19) from the CDC.

Feature | Coronavirus (COVID-19) | February 25, 2020 | Dave Fornell, Editor
The Centers for Disease Control and Prevention (CDC) said it is working to contain the spread of the novel coronavirus...
Tufts Medical Center created a heart failure team approach to care for its patients. The program includes an interventional heart failure fellowship program, where interventional cardiologists learn more advanced care, as show here with an ECMO procedure being performed in a cath lab at Tufts. The interventional cardiologists learn how to better care for heart failure patients and interface with surgeons, intensivists and others on the HF care team. The operator is Nevin Kapur. Photo by Dave Fornell.

Tufts Medical Center created a heart failure team approach to care for its patients. The program includes an interventional heart failure fellowship program, where interventional cardiologists learn more advanced hemodynamic support methods, as shown here with an ECMO procedure being performed in a cath lab at Tufts. The interventional cardiologists learn how to better care for heart failure patients and interface with surgeons, intensivists and others on the HF care team. Photo by Dave Fornell.

Feature | Heart Failure | February 20, 2020 | Dave Fornell, Editor
There is no, single magic bullet in heart failure (HF) to easily reduce readmission rates or easily reverse this...
A 3-D rendering created from the chest CT scan of a 41-year-old coronavirus patient in China showing ground-glass opacities in several areas of the lungs from the coronavirus pneumonia. This was from one of the first medical imaging studies published on COVID-19 in the journal Radiology. #coronavirus #COVID2019 #COVID19 #2019nCoV #SARS‐CoV‐2

A 3-D rendering created from the chest CT scan of a 41-year-old coronavirus patient in China showing ground-glass opacities in several areas of the lungs from the coronavirus pneumonia. This was from one of the first medical imaging studies published on COVID-19 in the journal Radiology. 

Feature | Coronavirus (COVID-19) | February 20, 2020 | Dave Fornell, Editor
(Article updated May 27, 2020) February 20, 2020 — The American College of Cardiology (ACC) released a clinical...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
Here is an example of Fitbit data showing comparisons of data from Fitbit users by state. Residents in some states that take more steps in a day typically have lower incidences of diabetes, as showing in this population health big data heat map from consumer-grade wearable health tracking devices..

Here is an example of Fitbit data showing comparisons of data from Fitbit users by state. Residents in some states that take more steps in a day typically have lower incidences of diabetes, as shown in this heat map.
 

Feature | Population Health | February 14, 2020 | Dave Fornell, Editor
The Centers for Disease Control and Prevention (CDC) highlights physical activity as one of four key behaviors people...
The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system, left, became the first TMVR device to gain commercial regulatory clearance in the world. It gains European CE mark in January. Another top story in January was the first use of the Robocath R-One robotic cath lab catheter guidance system in Germany.  Watch a VIDEO of the system in use in one of those cases. 

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system, left, became the first TMVR device to gain commercial regulatory clearance in the world. It gains European CE mark in January. Another top story in January was the first use of the Robocath R-One robotic cath lab catheter guidance system in Germany.  Watch a VIDEO of the system in use in one of those cases. 

News | February 03, 2020 | Dave Fornell, Editor
February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
Easy access, anywhere to the ECG management system is helpful in patient care. This is the GE Muse system accessed at the patient bedside.

Easy access, anywhere to the ECG management system is helpful in patient care. This is the GE Muse system accessed at the patient bedside. 

News | ECG Management Systems | January 29, 2020 | Dave Fornell, Editor
The movement from paper electrocardiogram (ECG) review to electronic ECG management systems in the past decade has...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Endovascular Aortic Repair | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA...
This is an example of artificial intelligence automation for cardiac MRI using an AI app from TeraRecon's Envoy AI marketplace. The GE MRI image has bee countoured, anatomy labeled and all quantification automated by the AI, greatly reducing post-processing time. See this and other new AI imaging technologies from the 2019 RSNA meeting.

This is an example of artificial intelligence automation for cardiac MRI using an AI app from TeraRecon's Envoy AI marketplace. The GE MRI image has been countoured, anatomy labeled and all quantification automated by the AI, greatly reducing post-processing time. See this and other new AI imaging technologies from the 2019 RSNA meeting.

Blog | January 24, 2020
The key question I am always asked at cardiology conferences is what are the trends and interesting new technologies I...
The VidaLink wireless, remote, wearable ECG patch patient monitor.  It consisting of reusable wearable electrocardiogram (ECG) sensors and associated software development kit (SDK). The sensor platform gives developers and providers direct control over data, and represents the first of its kind to receive FDA clearance.

The VidaLink wireless, remote, wearable ECG patch patient monitor.  It consisting of reusable wearable electrocardiogram (ECG) sensors and associated software development kit (SDK). The sensor platform gives developers and providers direct control over data, and represents the first of its kind to receive FDA clearance. Photo of the device on display at HIMSS 2019. Photo by Dave Fornell.

News | January 22, 2020
January 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared VivaLNK's Continuous ECG Platform. It consisting...